“Viva Rus” and IC&G plan to establish a joint company

“Viva Rus” and IC&G plan to establish a joint companyIn November 15, 2013 the Biofund RVC, Institute of Cytology and Genetics of the the Siberian branch of the Russian Academy of science (IC&G) and the Company “Viva Rus” within the International Forum of Technological development “Technoprom-2013”, have executed the memorandum on intention to establish the infrastructural company for provision of investigation services to developers in the segment “Life science”.

Co-founders of the company are the portfolio company of the Biofund RVC – “Viva Rus” and the IC&G. The total volume of the attracted financing will comprise up to 30M RUB. The company will work by the principal of pre-clinical contract research organization (CRO).

The aim of cooperation is establishment of a commercial service with compliance to international standards, based on the best global practice. The basis for creation will become the Center for collective use of the SPF-Vivarium, created in the IC&G.

The establishment of the infrastructural company depends on the demand growth on high-technology pre-clinical services for developers of medicaments and medicine technologies. Modern requirements to quality of experiments’ conduction conditions, used laboratory animals and regulations are very high and not available to most of existing laboratories in Russia.

“Together with the “Viva Rus” and with support of the Biofund RVC, we are planning to realize the most successful business-model of the service company; - notes Kolshanov N.A., director of the IC&G. – We hope that in a short-term perspective the company, using scientific-technology potential of the IC&G SPF-vivarium, can steadily enter the Russian market with competitive offer of international level services”.

Within the cooperation limits it is expected to organize and conduct pre-clinical research of security and efficiency of medical drugs, mainly in the sphere of oncology, endocrinology and inflammatory process. One of directions of the work at the initial stage will become conduction of trainings and programs for staff education. The attention focus will be directed on provision of required quality control for investigations in compliance with domestic, national and international standards, and also receiving certification and accreditation from the leading organizations.

“In Russia during a long period of time exists the deficit of service infrastructure, focused on early stages of R&D, - says Yegor Beketov, director general of the Biofund RVC – the joint project between the “Viva Rus” and IC&G possesses all chances to provide an opportunity to developers of getting global level services in Russia”.





https://www.venture-news.ru/ipo-news/64680-mozhno-li-vyigrat-v-kazino-vsya-pravda-kotoraya-shokiruet-kazhdogo.html